|
Sex (n, %)
| | |
0.29
|
|
Male
|
55 (53.4)
|
39 (61.9)
| |
|
Female
|
48 (46.6)
|
24 (38.1)
| |
|
Age (mean ± SD)
|
67 (±14.28)
|
69 (±11.18)
|
0.29
|
|
Vasc. risk-factors (n, %)
|
|
Art. hypertension
|
69 (67)
|
45 (71.4)
|
0.55
|
|
Smoking
|
27 (27.3)
|
23 (37.1)
|
0.19
|
|
Diabetes
|
17 (16.5)
|
14 (22.2)
|
0.36
|
|
Dyslipidemia
|
39 (37.9)
|
23 (36.5)
|
0.86
|
|
Atrial fibrillation
|
25 (24.3)
|
21 (33.3)
|
0.21
|
|
Baseline medication (n, %)
|
|
Aspirin
|
28 (28.9)
|
12 (20)
|
0.22
|
|
Clopidogrel
|
3 (3.1)
|
2 (3.3)
|
0.93
|
|
Anticoagulation
|
0 (0)
|
18 (28.6)
|
< 0.001
|
|
NIHSS at admission (median points, IQR)
|
12 (7–16)
|
10 (5–15)
|
0.14
|
|
Symptom-onset to admission (median time, IQR)
|
69 (40–171)
|
205 (73–508)
|
< 0.001
|
|
ASPECTS (median points, IQR)
|
9 (8–10)
|
8 (7–10)
|
0.01
|
|
General anesthesia (n, %)
|
68 (66)
|
41 (65)
|
0.16
|
|
Treatment adverse event (n, %)
|
12 (11)
|
8 (12)
|
0.72
|
|
NIHSS at discharge (median points, IQR)
|
2 (0–4)
|
2 (1–3)
|
0.24
|
|
mTICI ≥2b after EVT (n, %)
|
98 (95)
|
60 (95)
|
0.65
|
|
Stroke etiology (n, %)
|
|
Large-artery atherosclerosis
|
22 (21)
|
16 (25)
|
0.57
|
|
Cardioembolism
|
37 (36)
|
27 (43)
|
0.41
|
|
Small-vessel occlusion
|
0 (0)
|
1 (1)
|
0.38
|
|
Stroke of other determined etiology
|
9 (9)
|
2 (3)
|
0.21
|
|
Stroke of undetermined etiology
|
23 (22)
|
15 (24)
|
0.85
|
|
Stroke localization (n, %)
|
|
Right hemispheric stroke
|
56 (54)
|
29 (46)
|
0.44
|
|
Left hemispheric stroke
|
34 (33)
|
27 (43)
|
0.44
|
|
Vertebrobasilar stroke
|
13 (13)
|
7 (11)
|
0.99
|
|
A. cerebri anterior
|
1 (1)
|
0 (0)
|
0.99
|
|
A. cerebri media M1 proximal
|
33 (32)
|
28 (44)
|
0.14
|
|
A. cerebri media M1 distal
|
26 (25)
|
14 (22)
|
0.71
|
|
A. cerebri media M2
|
23 (22)
|
13 (21)
|
0.85
|
|
A. carotis interna T
|
10 (10)
|
5 (8)
|
0.79
|
|
A. carotis interna extracranial
|
2 (2)
|
2 (3)
|
0.64
|
